FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

96225007: Delta-9-tetrahydrocannabinol (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2008. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3700255014 Delta-9-tetrahydrocannabinol (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3700256010 Delta-9-tetrahydrocannabinol en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Delta-9-tetrahydrocannabinol (substance) Is a marihuanaderivat false Inferred relationship Some
Delta-9-tetrahydrocannabinol (substance) Is a Marijuana derivative false Inferred relationship Some
Delta-9-tetrahydrocannabinol (substance) Is a Tetrahydrocannabinol true Inferred relationship Some
Delta-9-tetrahydrocannabinol (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Cannabinoid receptor agonist true Inferred relationship Some
Delta-9-tetrahydrocannabinol (substance) This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. Tetrahydrocannabinol false Inferred relationship Some
Delta-9-tetrahydrocannabinol (substance) Is a Phytocannabinoid (substance) false Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Delta-9-tetrahydrocannabinol measurement Has measured component False Delta-9-tetrahydrocannabinol (substance) Inferred relationship Some
Delta-9-tetrahydrocannabinol measurement Component True Delta-9-tetrahydrocannabinol (substance) Inferred relationship Some 1
(s) delta-9-tetrahydrocannabinol 27 mg/ml og cannabinol 25 mg/ml, spray til bukkal anvendelse The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Delta-9-tetrahydrocannabinol (substance) Inferred relationship Some
delta-9-tetrahydrocannabinol + cannabinol The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Delta-9-tetrahydrocannabinol (substance) Inferred relationship Some 2
Dronabinol (substance) Is a False Delta-9-tetrahydrocannabinol (substance) Inferred relationship Some
Product containing only cannabinol and delta-9-tetrahydrocannabinol (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Delta-9-tetrahydrocannabinol (substance) Inferred relationship Some 2
Product containing precisely cannabidiol 25 milligram/1 milliliter and delta-9-tetrahydrocannabinol 27 milligram/1 milliliter conventional release oromucosal spray (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Delta-9-tetrahydrocannabinol (substance) Inferred relationship Some 2
Product containing precisely cannabidiol 25 milligram/1 milliliter and delta-9-tetrahydrocannabinol 27 milligram/1 milliliter conventional release oromucosal spray (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Delta-9-tetrahydrocannabinol (substance) Inferred relationship Some 2
Product containing cannabidiol and delta-9-tetrahydrocannabinol (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Delta-9-tetrahydrocannabinol (substance) Inferred relationship Some 2
Cannabidiol and delta-9-tetrahydrocannabinol only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Delta-9-tetrahydrocannabinol (substance) Inferred relationship Some 2
Product containing cannabidiol and delta-9-tetrahydrocannabinol in oromucosal dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Delta-9-tetrahydrocannabinol (substance) Inferred relationship Some 2
Product containing only cannabidiol and delta-9-tetrahydrocannabinol in oromucosal dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Delta-9-tetrahydrocannabinol (substance) Inferred relationship Some 2

This concept is not in any reference sets

Back to Start